InsidersTradesSigma
Total declarations
Companies
▲ Purchases (15 ops.)
▼ Sales (3 ops.)
Insider track record
OtherDisclosed buys
15
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Column Group Iii Gp, Lp. Officer active across 2 companies, notably Tenaya Therapeutics, Inc.. Aggregated, 19 reports have been published. Breakdown: 15 buys · 3 sells. Total volume traded: €69.4m. Activity tracked since 3 August 2021. The latest transaction was filed on 24 February 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Column Group Iii Gp, Lp
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations19 total
309,228 shares@ US$0.61530.3% of flowCommon StockSEC:0001193125-26-076814:0
245,965 shares@ US$0.61490.2% of flowCommon StockSEC:0001193125-26-067007:0
161,422 shares@ US$0.81610.072% mcap50.0% of flowCommon StockSEC:0001193125-26-049028:0
5,590 shares@ US$19.8891.2% of flowCommon StockSEC:0001193125-26-016991:0
Canonical exit: 15 Apr 2026 (T+90)
5,861 shares@ US$19.80411.2% of flowCommon StockSEC:0001193125-26-014100:0
Canonical exit: 13 Apr 2026 (T+90)
7,097 shares@ US$19.88721.5% of flowCommon StockSEC:0001193125-26-007857:0
Canonical exit: 6 Apr 2026 (T+90)
2,475 shares@ US$17.3470.5% of flowCommon StockSEC:0001193125-25-311384:0
Canonical exit: 4 Mar 2026 (T+90)
148,150 shares@ US$12.6521.0% of flowCommon StockSEC:0001193125-25-284943:0
Canonical exit: 11 Feb 2026 (T+90)
323,886 shares@ US$11.6057.3% of flowCommon StockSEC:0000950170-25-047104:0
Canonical exit: 24 Jun 2025 (T+90)
35,714,284 shares@ US$0.7038.5% of flowCommon StockSEC:0000950170-25-035789:0
Canonical exit: 3 Jun 2025 (T+90)
90,897 shares@ US$15.5021.4% of flowCommon StockSEC:0000950170-24-045118:0
Canonical exit: 3 Jul 2024 (T+90)
90,897 shares@ US$15.5021.4% of flowCommon StockSEC:0000950170-24-042633:0
Canonical exit: 3 Jul 2024 (T+90)
2,222,222 shares@ US$4.5015.1% of flowCommon StockSEC:0000950170-24-015234:0
Canonical exit: 12 May 2024 (T+90)
6,779 shares@ US$2.59560.0% of flowCommon StockSEC:0000899243-23-008390:0
Canonical exit: 8 Jun 2023 (T+90)
1,500,000 shares@ US$2.605.9% of flowCommon StockSEC:0000899243-23-004584:0
Canonical exit: 9 May 2023 (T+90)
69,739 shares@ US$2.49790.3% of flowCommon StockSEC:0000899243-23-002382:0
Canonical exit: 19 Apr 2023 (T+90)
49,463 shares@ US$2.49470.2% of flowCommon StockSEC:0000899243-23-002161:0
Canonical exit: 17 Apr 2023 (T+90)
9,615,384 shares@ US$2.6039.6% of flowCommon StockSEC:0000899243-22-036910:0
Canonical exit: 19 Feb 2023 (T+90)
4,389,282 shares0Common StockSEC:0001209191-21-049769:0
19 of 19 declarations
About Column Group Iii Gp, Lp
COLUMN GROUP III GP, LP is a declarant linked to Tenaya Therapeutics, Inc. and Surrozen, Inc./DE. It has 14 filings in total. Across the sampled recent filings from 2021-08-04 to 2026-02-12, buys total 66994667 EUR and sells total 221330 EUR, with the dominant transaction nature indicated as Acquisition.
